International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.14211008
Original Research Article
Study of Serum Calcium Changes in Neonates Receiving Phototherapy for Neonatal Hyperbilirubinemia
Published
Dec. 26, 2024
Abstract

Introduction: Phototherapy is considered to be a risk factor for hypocalcemia and its mechanism is probably multifactorial.Objective: 1) To determine the effect of phototherapy on serum Calcium level in neonates receiving phototherapy. 2) To compare Serum Calcium level changes in preterm and term neonates.Study Design: present study is a prospective hospital based comparative study conducted over a period of 1yr.Result: The study included 100 neonates. The majority of study participants i.e, 75 were born at term whereas, 25 were born preterm. Among preterm infants, the mean serum calcium level before phototherapy was 8.96±0.62 mg/dl, which decreased to 8.39±0.76 mg/dl after phototherapy. Among term infants, the mean serum calcium level before phototherapy was 9.08±0.61 mg/dl, which decreased to 8.38±0.77 mg/dl after phototherapy.Conclusion: The present study suggested that phototherapy is associated with significant reductions in serum calcium particularly in term infants. Preterm infants also showed significant changes in serum calcium levels, emphasizing their vulnerability and the need for close monitoring.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1876 Views
165 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved